Scarica l'app Stockscreener
390.43
0.16%
-0.64
Dopo l'orario di chiusura:
393.09
2.66
+0.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$391.07
Aprire:
$394.15
Volume 24 ore:
1.60M
Relative Volume:
1.23
Capitalizzazione di mercato:
$148.84B
Reddito:
$22.60B
Utile/perdita netta:
$2.99B
Rapporto P/E:
50.31
EPS:
7.76
Flusso di cassa netto:
$3.49B
1 W Prestazione:
-0.78%
1M Prestazione:
+7.78%
6M Prestazione:
+18.23%
1 anno Prestazione:
+23.30%
Intervallo 1D:
$389.30
$400.56
Intervallo di 1 settimana:
$386.77
$406.19
Portata 52W:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
390.43 | 148.84B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
128.81 | 223.42B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.04 | 151.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
91.99 | 117.96B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.22 | 43.19B | 6.60B | 4.16B | 490.10M | 6.93 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office - Quantisnow
Stryker Corporation (SYK) Announces CFO Transition - GuruFocus.com
Form 424B5 STRYKER CORP - StreetInsider.com
Stryker Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Canada Finance
Stryker Co. (NYSE:SYK) Shares Sold by Hantz Financial Services Inc. - MarketBeat
Stryker Co. (NYSE:SYK) Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Stryker's SWOT analysis: medical tech giant's stock poised for growth - Investing.com
Strong Segmental Performance to Drive Stryker's Q4 Earnings? - MSN
Stryker Corp’s Strong Earnings Call Highlights Growth and Strategy - TipRanks
Stryker beats Q4 estimates, sells spinal implants biz - MSN
Stryker Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth - AOL
A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts - Benzinga
Stryker Stock Falls on Deal to Sell Its U.S. Spinal Implants Business - Yahoo Finance Australia
Stryker sells spine implants business, sales up - BioWorld Online
Stryker to Sell its U.S. Spinal Implants Business - Yahoo Finance
Stryker (NYSE:SYK) Price Target Raised to $445.00 - MarketBeat
Nvest Financial LLC Has $833,000 Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker (NYSE:SYK) Price Target Raised to $440.00 at Stifel Nicolaus - MarketBeat
Stryker (NYSE:SYK) Receives Buy Rating from Needham & Company LLC - MarketBeat
Stryker Corporation (NYSE:SYK) Q4 2024 Earnings Call Transcript - Insider Monkey
Stryker to sell spinal implants business - Yahoo Finance
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings - Benzinga
Pacer Advisors Inc. Grows Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Buys 870 Shares of Stryker Co. (NYSE:SYK) - MarketBeat
Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Stryker Exceeds Profit Forecasts And Plans Strategic Divestment - Finimize
Stryker: Q4 Earnings Snapshot - Barchart
Stryker Corp Announces Robust 2024 Sales Growth - TipRanks
Earnings call transcript: Stryker Q4 2024 earnings beat forecasts - MSN
Stryker (SYK) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Stryker forecasts 2025 profit above estimates on robust demand for surgical devices - MSN
Stryker: Q4 Earnings Snapshot -January 28, 2025 at 04:30 pm EST - Marketscreener.com
Stryker will sell spine implant business; CFO set to retire - Mass Device
Stryker (NYSE:SYK) Issues Earnings Results - MarketBeat
Stryker to sell its U.S. spinal implants business - Modern Healthcare
Stryker (SYK) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Stryker to sell US spinal implants business to Viscogliosi Brothers - Investing.com India
Stryker appoints new CFO as Boehnlein retires - Investing.com India
Stryker (NYSE:SYK) Releases FY 2025 Earnings Guidance - MarketBeat
Stryker Announces CFO Transition Effective April 2025 - TipRanks
Stryker Corp Reports Q4 Revenue of $6.4 Billion, Exceeding Estimates; EPS Falls Short at $1.41 - GuruFocus.com
Stryker Sees Further Organic Sales Growth in 2025 -January 28, 2025 at 04:56 pm EST - Marketscreener.com
Stryker Earnings Report: Q4 Overview - Benzinga
Stryker Financial Chief Boehnlein to Retire; Wells Named as Successor -January 28, 2025 at 04:47 pm EST - Marketscreener.com
Stryker to Sell Spinal Implants Business to Viscogliosi Brothers -January 28, 2025 at 04:47 pm EST - Marketscreener.com
Stryker Earnings Review: Q4 Summary - Benzinga
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat - Yahoo! Voices
Stryker to Sell Spinal Implants Business to Viscogliosi Brothers - MarketWatch
Stryker Q4 Earnings Assessment - Benzinga
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):